COVID 19
The Institute is actively engaged in cutting-edge research on COVID-19, focusing on immunology, vaccine development, diagnostics, and viral evolution. Our work aims to enhance pandemic preparedness and improve patient outcomes. Below are the key areas of COVID-19 research at IDM:
T- and B-Cell Immunology
Understanding immune responses to SARS-CoV-2 is critical for effective treatments and vaccines. IDM’s research includes:
-
Investigating T-cell and B-cell responses to natural infection and vaccination.
-
Identifying immune markers associated with long-term immunity and protection.
-
Exploring immune evasion mechanisms and their impact on reinfection and disease severity.
Vaccine & Diagnostics Development
Ensuring the availability of effective vaccines and diagnostic tools is a priority. Our efforts focus on:
-
Developing next-generation vaccines with improved durability and broad protection.
-
Evaluating vaccine efficacy against emerging variants.
-
Innovating rapid and accurate diagnostic tests to detect SARS-CoV-2 and its variants.
Viral Evolution
Tracking SARS-CoV-2 mutations helps inform public health strategies. IDM’s research includes:
-
Studying viral adaptations and their effects on transmissibility and immune escape.
-
Analysing how mutations influence disease severity and treatment outcomes.
-
Modelling viral evolution to predict future variants.
Genomic Surveillance
Monitoring SARS-CoV-2 genetic changes is essential for controlling outbreaks. Our work includes:
-
Conducting real-time sequencing to track variant emergence and spread.
-
Integrating genomic data with epidemiological studies to inform policy decisions.
-
Collaborating with global networks to enhance surveillance and response efforts.